Home-use HIV tests
This article was originally published in The Gray Sheet
Executive Summary
FDA review of Johnson & Johnson's application to market its Confide home HIV sample collection kit appears to be progressing following the review of the policy issues by an agency advisory panel in June ("The Gray Sheet" June 27, p. 6). Senior FDA executives are understood to have alerted the Clinton Administration that the agency sees no policy impediments to approving an over-the-counter HIV test kit. Speaking at a Sept. 19 meeting sponsored by FDA and the Parenteral Drugs Association, FDA Deputy Commissioner Mary Pendergast said that "as far as [FDA is] concerned, home-based collection kits for the HIV virus do not pose major regulatory difficulties if they are accurate and people can get counseling" from professional
You may also be interested in...
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.